Colitrol IV Injection

✔️ Colitrol is indicated for the management of:

• Post-menopausal osteoporosis
• Renal osteodystrophy
• Postsurgical hypoparathyroidism
• Idiopathic hypoparathyroidism
• Pseudohypoparathyroidism
• Secondary hyperparathyroidism in moderate to severe chronic renal failure (pre-dialysis)
• Vitamin D-dependent rickets

✔️ Dosage & Administration

Dosing recommendations are based on serum calcium levels and the condition being treated.

Post-menopausal Osteoporosis:

• Oral dose: 0.25 mcg twice daily.

Renal Osteodystrophy (dialysis patients):

• Initial dose: 0.25 mcg daily.
• For normal or slightly reduced calcium levels: 0.25 mcg every other day may suffice.

Hypoparathyroidism and Rickets:

• Initial dose: 0.25 mcg/day (in the morning).
• If no response in 2–4 weeks, increase the dose at 2–4-week intervals.

Secondary Hyperparathyroidism (Pre-dialysis):

• Adults and children aged ≥3 years: 0.25 mcg/day, increased to 0.5 mcg/day if needed.
• Children aged <3 years: 10–15 ng/kg/day.

Intravenous administration:

• Initial dose: 1 mcg (0.02 mcg/kg) to 2 mcg three times weekly (every other day).
• Doses can range from 0.5 mcg to 4 mcg based on severity and response.
• Dose adjustments should occur at 2–4-week intervals.

1. Children:
   • Pre-dialysis secondary hyperparathyroidism: Initial dose is 10–15 ng/kg/day for children <3 years.
2. Elderly:
   • No specific dose adjustments are required.

✔️ Side Effects

Early side effects:

• Weakness, headache, somnolence, nausea, vomiting, dry mouth, constipation, muscle pain, metallic taste.

Late side effects:

• Polyuria, polydipsia, anorexia, weight loss, conjunctivitis (calcific), pancreatitis, photophobia, pruritus, nocturia, rhinorrhea, cardiac arrhythmias, and rarely psychosis.

Injection-related side effects:

• Occasional mild pain at the injection site.

✔️ Interaction

Thiazide diuretics:

• Risk: Increases hypercalcemia risk.
• Recommendation: Monitor calcium levels closely.

Digitalis treatment:

• Risk: Hypercalcemia may precipitate cardiac arrhythmias.
• Recommendation: Use with caution.

Magnesium-containing drugs:

• Risk: May cause hypermagnesemia.
• Recommendation: Avoid concurrent use.

✔️ Contraindications

• Known hypersensitivity to any component of Colitrol.
• Diseases associated with hypercalcemia.

✔️ Pregnancy & Lactation

• Pregnancy: Use only if benefits outweigh potential risks.
• Lactation: Serum calcium levels of mother and infant should be monitored during breastfeeding.

✔️ Precautions & Warnings

• Avoid excessive dosage as it may cause hypercalcemia and, in some cases, hypercalciuria.
• Use cautiously in patients receiving digitalis to prevent cardiac arrhythmias.
• Discontinuation may cause a rebound effect; adjust the dose downward carefully.
• Vitamin D and its derivatives should not be administered during Colitrol therapy.
• Chronic hypercalcemia can lead to:
  • Generalized vascular calcification.
  • Nephrocalcinosis.
  • Soft tissue calcification.
• Use a non-aluminum phosphate binder to control serum phosphorus levels in dialysis patients.

✔️ Storage Conditions

• Store in a dry place, away from light and heat.
• Keep out of reach of children.